

Background: The IQVIA Institute for Human Data Science will offer a multi-stakeholder webinar to discuss the level of readiness for radioligand therapy (RLT) in different European countries.
This is a non-commercial event hosted by the IQVIA Institute for Human Data Science with support from Novartis. Participation is open to the public at no cost.
We will discuss:
Agenda
Pr. Frédéric Courbon, MBA
Scientific Advisor
VECT-HORUS
Ken Herrmann, MD
Chair, Department of Nuclear Medicine
Universitatslmedizin Essen
Panos Kanavos, Ph.D
Deputy Director
London School of Economics
Jayne Spink, Ph.D.
Director, Translational Research
Prostate Cancer Research
Jasminka Taleska
Director, RLT HCS Readiness & Policy
Novartis